Higher insulin concentrations are required to suppress gluconeogenesis than glycogenolysis in nondiabetic humans

Diabetes

Volumn 52, Issue 9, 2003, Pages 2213-2220

  Adkins, Aron ^b   Basu, Rita ^b   Persson, Mai ^b   Dicke, Betty ^b   Shah, Pankaj ^b   Vella, Adrian ^b   Schwenk, W Frederick ^b   Rizza, Robert A ^a  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLUCOSE 6 PHOSPHATE; GLYCOGEN; INSULIN; URIDINE DIPHOSPHATE GLUCOSE;

ADULT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; GLYCOGENOLYSIS; HUMAN; HUMAN EXPERIMENT; INSULIN METABOLISM; MALE; NORMAL HUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM;

ADULT; BLOOD GLUCOSE; C-PEPTIDE; FEMALE; GLUCAGON; GLUCONEOGENESIS; GLUCOSE; GLYCOGEN; HORMONES; HUMAN GROWTH HORMONE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; SOMATOSTATIN; TRITIUM; URIDINE DIPHOSPHATE GLUCOSE; WATER;

EID: 0042320958     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.9.2213     Document Type: Article

References (38)

1. Bishop JS, Steele R, Altszuler N, Dunn A, Bjerknes C, De Bodo RC: Effects of insulin on liver glycogen synthesis and breakdown in the dog. Am J Physiol 208:307-316, 1965
2. Guignot L, Mithieux G: Mechanisms by which insulin, associated or not with glucose, may inhibit hepatic glucose production in the rat. Am J Physiol 277:E984-E989, 1999
3. Basu A, Basu R, Shah P, Vella A, Johnson CM, Nair KS, Jensen MD, Schwenk WF, Rizza RA: Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchric and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity. Diabetes 49:272-283, 2000
4. Hornbuckle LA, Edgerton DS, Ayala JE, Svitek CA, Oeser JK, Neal DW, Cardin S, Cherrington AD, O'Brien RM: Selective tonic inhibition of G-6-pase catalytic subunit, but not G-6-P transporter, gene expression by insulin in vivo. Am J Physiol Endocrinol Metab 281:E713-E725, 2001
5. Van Schaftingen E, Gerin I: The glucose-6-phosphatase system. Biochem J 362:513-532, 2002
6. Pilkis SJ, Weber IT, Harrison RW, Bell GI: Glucokinase: structural analysis of a protein involved in susceptibility to diabetes. J Biol Chem 269:21925-21928, 1994
7. Hers HG: The control of glycogen metabolism in the liver. Annu Rev Biochem 45:167-187, 1976
8. Witters LA, Avruch J: Insulin regulation of hepatic glycogen synthase and phosphorylase. Biochem 17:406-410, 1978
9. Petersen KF, Laurent D, Rothman DL, Cline GW, Shulman GI: Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans. J Clin Invest 101:1203-1209, 1998
10. Jetton TL, Magnuson MA: Heterogeneous expression of glucokinase among pancreatic β cells. Proc Natl Acad Sci U S A 89:2619-2623, 1992
11. Mayo Johnson ME, Das NM, Butcher FR, Fain JN: The regulation of gluconeogenesis in isolated rat liver cells by glucagon, insulin, dibutyryl cyclic adenosine monophosphate, and fatty acids. J Biol Chem 247:3229-3235, 1972
12. Edgerton DS, Cardin S, Enishwiller M, Neal D, Chandraniouli V, Schumann WC, Landau BR, Rossetti L, Cherrington AD: Small increases in insulin inhibit hepatic glucose production solely caused by an effect on glycogen metabolism. Diabetes 50:1872-1882, 2001
13. Chiasson JL, Liljenquist JE, Finger FE, Lacy WW: Differential sensitivity of glycogenolysis and gluconeogenesis to insulin infusions in dogs. Diabetes 25:283-291, 1976
14. Chiasson JL, Atkinson RL, Cherrington AD, Keller U, Sinclair-Smith BC, Lacy WW, Lijenquist JE: Effects of insulin at two dose levels on gluconeogenesis from alanine in fasting man. Metabolism 810-818, 1980
15. Gastaldelli A, Toschi E, Pettiti M, Frascerra S, Quiñones-Galvan A, Sironi AM, Natali A, Ferrannini E: Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients. Diabetes 50:1807-1812, 2001
16. Boden G, Cheung P, Stein TP, Kresge K, Mozzoli M: FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis. Am J Physiol Endocrinol Metab 283:E12-E19, 2002
17. Rizza RA, Mandarino LJ, Gerich JE: Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol 240:E630-E639, 1981
18. Landau BR, Wahren J, Chandramouli V, Schumann WC, Ekberg K, Kalhan SC: Contributions of gluconeogenesis to glucose production in the fasted state. J Clin Invest 98:378-385, 1996
19. Shulman GI, Cline G, Shuman WC, Chandrmouli V, Kumaran K, Landau BR: Quantitative comparison of pathways of hepatic glycogen repletion in fed and fasted humans. Am J Physiol 259:E335-E341, 1990
20. Hellerstein MK, Neese RA, Linfoot P, Christiansen M, Turner S, Letscher A: Hepatic gluconeogenic fluxes and glycogen turnover during fasting in humans: a stable isotope study. J Clin Invest 100:1305-1319, 1997
21. Rother KI, Schwenk WF: Hepatic glycogen accurately reflected by acetaminophen glucuronide in dogs refed after fasting. Am J Physiol 269: E766-E773, 1995
22. 2O administration. Anal Biochem 297:19.5-197, 2001
23. Chandramouli V, Ekberg K, Schumann WC, Kalhan SC, Wahren J, Landau BR: Quantifying gluconeogenesis during fasting. Am J Physiol 273:E1209-E1215, 1997
24. Diraison F, Large V, Brunengraber H, Beylot M: Non-invasive tracing of liver intermediary metabolism in normal subjects and in moderately hyperglycaemic NIDDM subjects. Evidence against increased gluconeo-genesis and hepatic fatty acid oxidation in NIDDM. Diabetologia 41:212-220, 1998
25. Boden G, Chen X, Stein TP: Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 280:E23-E30, 2001
26. Wong WW, Lee LS, Klein PD: Deuterium and oxygen-18 measurements on nucroliter samples of urine, plasma, saliva, and human milk. Am J Clin Nutr 45:905-913, 1987
27. Steele R, Wall J, DeBodo R, Altszuler N: Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 187:15-24, 1956
28. Magnusson I, Chandramouli V, Schumann WC, Kuniaran K, Wahren J, Landau BR: Quantitation of the pathways of hepatic glycogen formation on ingesting a glucose load. J Clin Invest 80:1748-1754, 1987
29. Wajngot A, Chandramouli V, Schumann WC, Efendic S, Landau BR: Quantitation of glycogen/glucose-1-P cycling in liver. Metabolism 40:877-881, 1991
30. DeFronzo RA, Ferrannini E, Hendler R, Felig P, Wahren J: Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes 32:35-45, 1983
31. Ortmeyer HK, Bodkin NL, Hansen BC: Insulin regulates liver glycogen synthase and glycogen phosphorylase activity reciprocally in rhesus monkeys. Am J Physiol Endocrinol Metab 272: E133-E138, 1997
32. Giaccari A, Morviducci L, Pastore L, Zorretta D, Sbraccia P, Maroccia E, Buongiorno A, Tamburrano G: Relative contribution of glycogenolysis and gluconeogenesis to hepatic glucose production in control and diabetic rats: a re-examination in the presence of euglycaemia. Diabetologia 41:307-314, 1998
33. Barzilai N, Rossetti L: Role of glucokinase and glucose-6-phosphatase in the acute and chronic regulation of hepatic glucose fluxes by insulin. J Biol Chem 268:25019-25025, 1993
34. Exton JH, Mallette LE, Jefferson LS, Wong EHA, Friedmann N, Miller TB, Park CR: The hormonal control of hepatic gluconeogenesis. Recent Prog Horm Res 26:411-457, 1970
35. Ichai C, Guignot L, El-Mir MY, Nogueira V, Guigas B, Chauvin C, Fontaine E, Mithieux G, Leverve XM: Glucose 6-phosphate hydrolysis is activated by glucagon in a low temperature-sensitive manner. J Biol Chem 276:28126-28133, 2001
36. Blackard WG, Nelson NC, Andrews SS: Portal and peripheral vein immunoreactive glucagon concentrations after arginine or glucose infusions. Diabetes 23:199-202, 1974
37. Jaspan JB, Ruddick J, Rayfield E: Transhepatic glucagon gradients in man: evidence for glucagon extraction by human liver. J Clin Endocrinol Metab 58:287-292, 1984
38. Raskin P, Fujita Y, Unger RH: Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics. J Clin Invest 56:1132-1138, 1975